维普中文期刊产品整合服务
35篇 您的检索式:作者名="TARIS R"
    题名 作者 年代 出处 被引量
1Adenomatioid tumors: alight microscopic, histochemical, and ultrastructural study 显示文摘Tary JB Battifora H Oysasu R 1974Cancer1974,34,:1
2KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2显示文摘Zang X P Siwak D R Nguyen T X Tari A M Pento J T 2004Clin Exp Metastasis2004,21,:1
3Workaholism, Burnout, and Work Engagement : Three of a Kind or Three Different Kinds of Employee Well - being? 显示文摘Schaufeli W B Taris T W Van R W 2008Applied Psychology : An International Review2008,57,2:1
4The RAGE axis in early diabetic retinopathy显示文摘Barile G R Pachydaki S I Tari S R 2005Invest Ophthalmol Vis Sci2005,46,8:1
5The Role of the Synergistic Phosphate Anion in Iron Transport by the Periplasmic Iron-binding Protein from Haemophilus Influenzae显示文摘Khan A G Shouldice S R Tari L W 0,,:1
6早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 2016中国全科医学2016,19,18:1
7Glutathione transferase supergene family in tomato: Salt stress-regulated expression of representative genes from distinct GST classes in plants primed with salicylic acid显示文摘Jolán Csiszár Edit Horváth Zsolt Váry ágnes Gallé Krisztina Bela Szilvia Brunner Irma Tari 2014Plant Physiology and Biochemistry2014,,:1
8High efficacy of bis- muth subcitrate for Helicobacter pylori eradication in pangas- tritis显示文摘Severi C Abdullahi M Tari R 2009Dig Liver Dis2009,41,:1
9Perceived fairness in personnel selection:Determinants and outcomes in different stages of the assessment procedure显示文摘Van Vianen A E M Taris R Scholten E Schinkel S 0,,1:1
10Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells显示文摘Tari AM Arlinghaus R Lopez-Berestein G 0,,2:1
11Police Interview Competencies:Assessment and Associated Traits显示文摘FRUYT F D BOCKSTAELE M TARIS R 2006European Journal of Personality2006,20,56:1
12Starch based spherical aggregates:reconfirmation of the role of amylose on the stability of a model flavouring compound,vanillin显示文摘Tari T A Singhal R S 2002Carbohydrates Polymers2002,50,:1
13Longitudinal Examination of the Relationship between Supplies-values Fit and Work Outcomes 显示文摘TARIS R FEIJ J 2001Applied Psychology : An International Review2001,50,1:1
14Predictors of job search behavior among employed and unemployed people显示文摘Van Hooft E A J Born M P H Taris T W Van der Flier H Blonk R W B 0,,01:1
15Reactive oxygen species mediated calcium oxalate crystal -induced expression of MCP-1 in HK-2 cells显示文摘HABIBZADEGAH TARI P BYER K G KHAN S R 2006Urol Res2006,34,1:1
16Oxalate in- duced expression of monocyte chemoattractant protein - 1 ( MCP - 1 ) in HK -2 ceils involves reactive oxygen species显示文摘HABIBZADEGAH TARI P BYER K KHAN S R 2005Urol Res2005,33,6:1
17MetaCDN: Harnessing storage clouds' for high performance content delivery 显示文摘Broberg J Buyya R Tari Z 2009Journal of Network and Computer Applications2009,32,5:1
18A context-aware ap- proach for long-term behavioural change detection and abnormality prediction in ambient assisted living显示文摘FORKAN A R M KHALIL I TARI Z 2015Pattern Recognition2015,48,3:1
19Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells 显示文摘Lim SJ Lopez-Berestein G Hung MC Lupu R Tari AM 2000Oncogene2000,19,54:1
20Starch based spherical aggregates: reconfirmation of the role of amylose on the stability of a model flavouring compound, vanillin 显示文摘Tari T A Singhal R S 2002Carbohydrates Polymers2002,,50:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费